Biodesix (BDSX) Cash from Operations (2019 - 2026)

Biodesix has reported Cash from Operations for 8 years, with the latest figure at 10168000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 18.21% year-over-year to 10168000.0; the trailing twelve-month figure through Mar 2026 stood at 24837000.0 (up 40.78% YoY), and the FY2025 full-year result was 23271000.0, up 52.17% from the prior year.
• Cash from Operations for Q1 2026 stood at 10168000.0, down from 778000.0 in the prior quarter.
• The five-year high for Cash from Operations was 937000.0 in Q2 2023, with the low at 18571000.0 in Q2 2024.
• Historically, Cash from Operations has averaged 8819411.76 across 5 years, with a median of 9594000.0 in 2022.
• Annual changes were most pronounced in 2024 — Cash from Operations sank 2081.96% — and 2025, when it jumped 118.99%.
• Biodesix's Cash from Operations stood at 11948000.0 in 2022, then declined by 2.8% to 12283000.0 in 2023, then jumped by 66.65% to 4096000.0 in 2024, then jumped by 118.99% to 778000.0 in 2025, then plunged by 1406.94% to 10168000.0 in 2026.
• The last three Cash from Operations figures came in at 10168000.0 (Q1 2026), 778000.0 (Q4 2025), and 8879000.0 (Q3 2025), per Business Quant data.